Your browser doesn't support javascript.
loading
Smoking, alcohol consumption and disease-specific outcomes in rheumatic and musculoskeletal diseases (RMDs): systematic reviews informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs.
Wieczorek, Maud; Gwinnutt, James Martin; Ransay-Colle, Maxime; Balanescu, Andra; Bischoff-Ferrari, Heike; Boonen, Annelies; Cavalli, Giulio; de Souza, Savia; de Thurah, Annette; Dorner, Thomas Ernst; Moe, Rikke Helene; Putrik, Polina; Rodríguez-Carrio, Javier; Silva-Fernández, Lucía; Stamm, Tanja A; Walker-Bone, Karen; Welling, Joep; Zlatkovic-Svenda, Mirjana; Verstappen, Suzanne Mm; Guillemin, Francis.
Afiliación
  • Wieczorek M; Centre on Aging and Mobility, University Hospital Zurich, Zurich City Hospital - Waid and University of Zurich, Zurich, Switzerland.
  • Gwinnutt JM; EA4360 Apemac, University of Lorraine, Vandoeuvre-lès-Nancy, France.
  • Ransay-Colle M; Centre for Epidemiology Versus Arthritis, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
  • Balanescu A; EA4360 Apemac, University of Lorraine, Vandoeuvre-lès-Nancy, France.
  • Bischoff-Ferrari H; Department of Internal Medicine and Rheumatology, "Sf. Maria" Hospital, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
  • Boonen A; Centre on Aging and Mobility, University Hospital Zurich, Zurich City Hospital - Waid and University of Zurich, Zurich, Switzerland.
  • Cavalli G; Department of Aging Medicine and Aging Research, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • de Souza S; University Clinic for Aging Medicine, City Hospital Zurich - Waid, Zurich, Switzerland.
  • de Thurah A; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Dorner TE; Care and Public Health Research Institute (CAPHRI), Maastricht Univeristy, Maastricht, The Netherlands.
  • Moe RH; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital and Vita-Salute San Raffaele University, Milan, Italy.
  • Putrik P; Centre for Rheumatic Diseases, King's College London, London, UK.
  • Rodríguez-Carrio J; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Silva-Fernández L; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.
  • Stamm TA; Centre for Public Health, Department of Social and Preventive Medicine, Medical University of Vienna, Vienna, Austria.
  • Walker-Bone K; Social Insurance Fund for Public Service, Railway and Mining Industries, Sitzenberg-Reidling, Austria.
  • Welling J; Karl-Landsteiner Institute for Health Promotion Research, Sitzenberg-Reidling, Austria.
  • Zlatkovic-Svenda M; National Advisory Unit for Rehabilitation in Rheumatology, Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.
  • Verstappen SM; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Guillemin F; Care and Public Health Research Institute (CAPHRI), Maastricht Univeristy, Maastricht, The Netherlands.
RMD Open ; 8(1)2022 03.
Article en En | MEDLINE | ID: mdl-35351808
ABSTRACT

BACKGROUND:

A EULAR taskforce was convened to develop recommendations for lifestyle behaviours in rheumatic and musculoskeletal diseases (RMDs). The aim of this paper was to review the literature on the relationship between smoking and alcohol consumption with regard to RMD-specific outcomes.

METHODS:

Two systematic reviews were conducted to identify systematic reviews and meta-analyses, published between 2013 and 2018, related to smoking and alcohol consumption in seven RMDs osteoarthritis (OA), rheumatoid arthritis (RA), systemic lupus erythematosus, axial spondyloarthritis (axSpA), psoriatic arthritis (PsA), systemic sclerosis (SSc) and gout. Two additional systematic reviews were performed to identify original longitudinal studies on smoking and alcohol consumption and disease-specific outcomes.

RESULTS:

Nine reviews and 65 original studies on smoking as well as two reviews and 14 original studies on alcohol consumption met the inclusion criteria. While most studies were moderate/poor quality, smoking was significantly associated with poorer

outcomes:

cardiovascular comorbidity; poorer response to RA treatment; higher disease activity and severity in early RA; axSpA radiographic progression. Results were heterogeneous for OA while there was limited evidence for PsA, SSc and gout. Available studies on alcohol mainly focused on RA, reporting a positive association between alcohol intake and radiographic progression. Five studies assessed alcohol consumption in gout, reporting a significant association between the number and type of alcoholic beverages and the occurrence of flares.

CONCLUSION:

Current literature supports that smoking has a negative impact on several RMD-specific outcomes and that moderate or high alcohol consumption is associated with increased risk of flares in RA and gout.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Artritis Reumatoide / Enfermedades Musculoesqueléticas Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Risk_factors_studies / Systematic_reviews Aspecto: Patient_preference Límite: Humans Idioma: En Revista: RMD Open Año: 2022 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Artritis Reumatoide / Enfermedades Musculoesqueléticas Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Risk_factors_studies / Systematic_reviews Aspecto: Patient_preference Límite: Humans Idioma: En Revista: RMD Open Año: 2022 Tipo del documento: Article País de afiliación: Suiza